Status:
COMPLETED
Vasoactive Intestinal Peptide in COPD
Lead Sponsor:
Medical University of Vienna
Conditions:
COPD
Pulmonary Hypertension
Eligibility:
All Genders
18-75 years
Brief Summary
This study, a new immunomodulatory therapy of COPD with vasoactive intestinal peptide (VIP) was evaluated. Based on preliminary unpublished clinical and experimental results, the course of disease und...
Detailed Description
Chronic obstructive bronchitis is a chronic inflammatory disease of the airways, which affects as many as 8% of individuals in industrialized nations. There is an increase in the number of woman and m...
Eligibility Criteria
Inclusion
- Confirmed moderate to severe COPD with or without pulmonary hypertension
- Male and female patients.
- Aged 18 - 75 years.
- Written consent.
- Adequate contraception in female patients of childbearing age.
- Negative pregnancy test (four-weekly test repetition).
Exclusion
- Lack of consent
- Pregnancy (four-weekly tests)
- Lactation
- Presumed non-cooperativeness
- Patients outside the stipulated age range
- Myocardial infarction within the last 12 months
- Stroke within the last 12 months
- Malignant diseases in anamnesis
- Legal incapacity
- Parallel participation in a clinical trial
- Parallel participation in a clinical trial within the last 4 weeks
Key Trial Info
Start Date :
June 1 2003
Trial Type :
OBSERVATIONAL
End Date :
July 1 2006
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT00464932
Start Date
June 1 2003
End Date
July 1 2006
Last Update
April 24 2007
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.